A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease.
about
Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectivesA Review of the Key Clinical Trials of 2015: Results and ImplicationsRecent advances in CKD and ESRD: A literature update.Emerging Targets of Diuretic Therapy.30 Years of the Mineralocorticoid Receptor: Mineralocorticoid receptor antagonists: 60 years of research and development.Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular-only pacing.The Three-Decade Long Journey in Heart Failure Drug Development.Future drug discovery in renin-angiotensin-aldosterone system intervention.Treatment of Hyperkalemia in Heart Failure.Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.New pharmacological approaches in heart failure therapy: developments and possibilities.Should All Patients with Resistant Hypertension Receive Spironolactone?Role of mineralocorticoid receptor activation in cardiac diastolic dysfunction.Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside.The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury.A Janus-headed electrolyte and 'RALES' disease'.Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial.Influence of renal impairment on aldosterone status, calcium metabolism, and vasopressin activity in outpatients with systolic heart failure.Genomic and rapid effects of aldosterone: what we know and do not know thus far.The use of a novel non-steroidal mineralocorticoid receptor antagonist finerenone for the treatment of chronic heart failure: A systematic review and meta-analysis.Progress in the Management of Primary Aldosteronism.Surrogate endpoints in heart failure: (once again) use with caution.
P2860
Q26741152-04988343-8036-411D-A20D-53879F8EC48BQ28077170-57EDF1F2-C3A9-4F5E-BA64-4EFB3CAC82FBQ30275339-9508B760-DB39-4C61-B675-D384CDF7BC72Q30402569-24653495-C1F6-43F1-A2C4-0EF5ECAEA63BQ33846431-30DA1B95-B91C-4CB6-BB08-3293CFF46D0EQ38373981-12E9937B-D230-4393-BAD5-0BD4B376E359Q38558614-1EF8520D-A062-499E-B31F-D4B0B5813FDDQ38679303-06857D20-2038-4192-B4FD-49CD2D87BA4EQ38705827-91F94E5C-15DD-4ACA-9D38-0BA0F464AD8FQ38750210-29ACE3ED-452F-4955-BEC8-62FE83F7CF8EQ38759494-79CB6F11-F67F-4970-AC45-E4344DE21C53Q38992649-B227A915-16AD-4C45-9321-9E3213159DAFQ39042819-B7D3642E-EFA6-42E3-A34E-0101CE87F5DBQ39199991-706903F0-F331-4B41-B470-6422556CB997Q41677231-75562B86-1E3B-4109-A512-EB24F269B0CCQ42341892-AD60F1A5-74B5-4669-9808-535EFEE93C95Q46198550-09D1948F-221E-4BDD-A013-1CFF6A71EDEAQ47575429-CD1EA9D5-A8A1-401F-BFB7-DD86D7985AA5Q51273122-DC2B9D4D-853F-4C81-8A12-F03CE517FCF1Q52580660-4CBCC2A7-2FFD-490E-98AD-C13831F34FD7Q52657939-1DCA9A99-7D76-44F8-87C4-B2FA57F64524Q53838113-A279EBA0-8EB8-451C-826E-0A948E245E34
P2860
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A randomized controlled study ...... and/or chronic kidney disease.
@en
A randomized controlled study ...... and/or chronic kidney disease.
@nl
type
label
A randomized controlled study ...... and/or chronic kidney disease.
@en
A randomized controlled study ...... and/or chronic kidney disease.
@nl
prefLabel
A randomized controlled study ...... and/or chronic kidney disease.
@en
A randomized controlled study ...... and/or chronic kidney disease.
@nl
P2093
P2860
P50
P356
P1476
A randomized controlled study ...... and/or chronic kidney disease.
@en
P2093
Adriaan A Voors
Alexander Pieper
Christina Nowack
Giovanni Palombo
Michael Böhm
Nina Kimmeskamp-Kirschbaum
Peter Kolkhof
So-Young Kim
P2860
P304
P356
10.1093/EURHEARTJ/EHW132
P50
P577
2016-04-29T00:00:00Z